Hideki Shimodaira

Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui et al. · Journal of Clinical Oncology · 2013 · 548 citations

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 215 citations

Gastrointestinal Oncology, Medicine, Advanced Gastric Cancer +5

Screening thep53 status of human cell lines using a yeast functional assay

Liqun Jia, Motonobu Osada, Chikashi Ishioka et al. · Molecular Carcinogenesis · 1997 · 177 citations

Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

Hideki Shimodaira, Atsuko Yoshioka-Yamashita, Richard D. Kolodner et al. · Proceedings of the National Academy of Sciences · 2003 · 173 citations · Full text

Chromatin, Genome Instability, Apoptosis Response +11

Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae

Hideki Shimodaira, Nicole Filosi, Hiroyuki Shibata et al. · Nature Genetics · 1998 · 154 citations

Genome Instability, Genetics, Yeast +4